Leading a team at Outpace Bio using AI-powered protein design to program immune cells to have improved function inside cancer patients (accessing the tumor, surviving, expanding, functionally persisting, and debulking large tumors). Our goal is to achieve durable responses by improving the functional persistence of engineered immune cell therapies.
Postdoc in protein design (David Baker lab, co-founded Lyell Immunopharma and Outpace Bio).
PhD in chemical biology with a focus on genome engineering and the genetic code (George Church lab, co-founded GRO Bio).
Specialties: T cell therapies, protein design, synthetic biology, genome design, genome engineering, next generation DNA sequencing, next generation gene synthesis